Amphotericin Pharmacophobia

December 1973
British Medical Journal;12/8/1973, Vol. 4 Issue 5892, p624
Academic Journal
Correction notice
No abstract available.


Related Articles

  • Nephrotoxicity of Different Formulations of Amphotericin B: Summarizing Evidence by Network Meta-analysis. Messori, Andrea; Fadda, Valeria; Maratea, Dario; Trippoli, Sabrina; Marinai, Claudio // Clinical Infectious Diseases;Dec2013, Vol. 57 Issue 12, p1783 

    A letter to the editor is presented related to amphotericin B's nephrotoxicity.

  • Cryptococcosis treated by rapid infusion of amphotericin B. Tarala, Richard A.; Smith, Justin D. // British Medical Journal;7/5/1980, Vol. 281 Issue 6232, p28 

    Investigates the efficacy of amphotericin B in treating pulmonary cryptococcosis. Side effects of amphotericin B; Significance of kidney secretion of amphotericin after intravenous infusion; Safety of amphotericin B infusion in treating pulmonary infection with Cryptococcus neoformans.

  • Comparison of Nephrotoxicity of Amphotericin B Products. Harrell, Colleen Carrigan; Honf-Kristufek, Lauryl // Clinical Infectious Diseases;3/15/2001, Vol. 32 Issue 6, p990 

    Focuses on a study which compared nephrotoxicity of amphotericin B lipid complex and conventional amphotericin B. Parameters for defining nephrotoxicity.

  • Amphotericin B Toxicity. Utz, John P.; Bennett, John E.; Brandriss, Michael W.; Butler, William T.; Hill II, George J. // Annals of Internal Medicine;Aug64, Vol. 61 Issue 2, p334 

    Focuses on the pharmacological aspects of antibiotic amphotericin B. Forms of amphotericin B in clinical use; Mechanism of action.

  • Liposomal amphotericin B in the treatment of fungal infections. Lopez-Berestein, Gabriel; Lopez-Berestein, G // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p130 

    Editorial. Discusses the use of amphotericin B, a polyene antibiotic, in the treatment of systemic fungal infections. Effectiveness of the agent for the treatment of leishmaniasis; Mechanism of action of amphotericin B; Definition of the term liposomes; Therapeutic use of liposomal amphotericin B.

  • amphotericin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p38 

    An encyclopedia entry for "amphotericin" is presented. It refers to an antifungal drug administered to treat candidiasis of the mouth or intestine. Amphotericin is taken either orally or by intravenous infusion. Adverse events related to amphotericin administration include vomiting, headache and...

  • Candidemia caused by amphotericin B and Fluconazole resistant Candida auris. Sarma, S.; Kumar, N.; Sharma, S.; Govil, D.; Ali, T.; Mehta, Y.; Rattan, A. // Indian Journal of Medical Microbiology;Jan-Mar2013, Vol. 31 Issue 1, p90 

    A letter to the editor is presented on Candidemia which is caused by amphotericin B and Fluconazole.

  • Treatment of Mucosal Leishmaniasis with a Lipid Formulation of Amphotericin B. Amato, Valdir Sabbaga; Tuon, Felipe Francisco; Campos, Aleia; Bacha, Helio Arthur; Nicodemo, Antonio Carlos; Neto, Vicente Amato; Shikanai-Yasuda, Maria Aparecida // Clinical Infectious Diseases;1/15/2007, Vol. 44 Issue 2, p311 

    A letter to the editor about the treatment of mucosal leishmaniasis with a lipid formulation of Amphotericin is presented.

  • Do Not Abandon Amphotericin B as an Antifungal Bladder Irrigant. Wise, Gilbert J. // Clinical Infectious Diseases;10/1/2005, Vol. 41 Issue 7, p1073 

    Presents a letter to the editor on the use of amphotericin B bladder irrigation for treatment of candiduria.

  • Liposomal Amphotericin B as a Cause of Pseudohyperphosphatemia. Mendoza, Daniel; Connors, Sheila; Lane, Clifford; Stehnach, Sam // Clinical Infectious Diseases;2/15/2008, Vol. 46 Issue 4, p645 

    A letter to the editor is presented concerning liposomal amphotericin B as a cause of pseudohyperphosphatemia.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics